GCNT2 Gene Cataract Autosomal Dominant NGS Genetic DNA Test
Introduction
The GCNT2 Gene Cataract Autosomal Dominant NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to assess genetic predispositions to cataracts. This test utilizes Next-Generation Sequencing (NGS) technology to analyze the GCNT2 gene, which plays a significant role in the formation of cataracts. Understanding your genetic risk is crucial for early intervention and management of cataracts, which can lead to vision impairment if left untreated.
What the Test Measures
This test specifically detects mutations in the GCNT2 gene that are associated with autosomal dominant cataracts. By identifying these genetic variations, healthcare providers can better understand an individual’s risk for developing cataracts.
Who Should Consider This Test
Individuals with a family history of cataracts or those experiencing early signs of cataract development should consider this test. Symptoms may include blurred vision, difficulty seeing at night, or increased sensitivity to glare. Risk factors such as age, genetic predisposition, and certain health conditions may also warrant testing.
Benefits of Taking the Test
- Identifies genetic risk factors for cataracts.
- Informs preventive measures and treatment options.
- Facilitates early diagnosis and management.
- Provides peace of mind for individuals concerned about their eye health.
Understanding Your Results
Results from the GCNT2 Gene Cataract test will provide insight into whether you carry mutations associated with cataracts. A genetic counselor will help interpret your results and discuss potential implications for your health and family.
Test Pricing
| Price Type | Amount (NGN) |
|---|---|
| Discount Price | 400,000 NGN |
| Regular Price | 560,000 NGN |
Booking the Test
To book the GCNT2 Gene Cataract Autosomal Dominant NGS Genetic DNA Test, please contact us via phone or WhatsApp at +2348077798758. Our team is ready to assist you with scheduling and any questions you may have.
Additional Information
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-Test Instructions: A clinical history of the patient is required, along with a genetic counseling session to draw a pedigree chart of family members affected by the GCNT2 gene cataract.
